Persistence Market Research Blog

Posts tagged ‘UCB Banking Industry’

Global Market Study on UCB Banking – Asia-Pacific to Witness Highest Growth by 2020

Umbilical cord blood (UCB) is collected from the umbilical cord of a newborn baby and also retrieved from the placenta after delivery. It is enriched with adult stem cells and these stem cells play a vital role in regulating all biological activities and in developing tissues in the human body. Many types of stem cells are present in UCB including hematopoietic stem cells and mesenchymal stem cells. Hematopoietic stem cells give rise to all the other blood cells. Hematopoietic stem cells are severely damaged in people suffering from bone marrow diseases, malignancies, inherited metabolic disorders, and immunological disorders. Mesenchymal stem cells are involved in the development of tissues such as cartilage, bone, fat, new blood vessels, and cardiac muscles.

UCB is used in clinical procedures associated with regenerative medicines. For instance, UCB-derived stem cells are used in hematopoietic stem cell transplantation (HSCT) for the treatment of life-threatening diseases such as leukemia and type I diabetes in children and adults. In addition, UCB is also used in the treatment of diseases such as bone marrow disorders, circulatory diseases, heart problems, neurological diseases, and cartilage disorders.

Globally, increasing prevalence of chronic diseases coupled with the emerging field of regenerative medicines is driving the UCB banking market. In addition, various government associations and initiatives are also supporting in the growth of the UCB banking market.

However, strict license and accreditation procedures impede the growth of UCB banking market. In addition, high banking cost in private UCB banks is also hampering the growth of UCB banking market. Allogeneic hematopoietic stem cell transplantation and cord tissue storage are some of the major trends in UCB banking market.

North America has the largest market for UCB banking. The U.S., followed by Canada, is the largest market for UCB banking in the region. Increasing prevalence of chronic diseases is key driver of UCB banking market in the region. In addition, various government associations have also led to the importance of cord blood donation and services for its future use in North America.

Complete report is available at


Tag Cloud